EVOK Evoke Pharma
- 0.4500
- +0.0100+2.27%
Evoke Pharma News
Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications
SOLANA BEACH, Calif., April 17, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on
Evoke Pharma Taps Operating Chief D'Onofrio to Succeed CEO Gonyer
By Denny Jacob Evoke Pharma tapped Matthew D'Onofrio to succeed David Gonyer as chief executive, effective March 31. D'Onofrio, who currently serves as president and chief operating officer, will as
Evoke Pharma: Gonyer's Departure Is for Personal Reasons >EVOK
Evoke Pharma: Gonyer's Departure Is for Personal Reasons >EVOK
Evoke Pharma : Matthew D'Onofrio Will Be Succeeding David Gonyer as CEO as of March 31 >EVOK
Evoke Pharma : Matthew D'Onofrio Will Be Succeeding David Gonyer as CEO as of March 31 >EVOK
Press Release: Evoke Pharma Announces Senior Leadership Transition With Promotion of Matthew J. D'Onofrio to Chief Executive Officer
Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D'Onofrio to Chief Executive Officer SOLANA BEACH, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASD
Evoke Pharma, Inc. (NASDAQ:EVOK): Are Analysts Optimistic?
Evoke Pharma, Inc. (NASDAQ:EVOK) Q4 2023 Earnings Call Transcript
Earnings Call Summary | Evoke Pharma(EVOK.US) Q4 2023 Earnings Conference
The following is a summary of the Evoke Pharma, Inc. (EVOK) Q4 2023 Earnings Call Transcript:Financial Performance:Evoke Pharma reported net revenue for GIMOTI doubled over the last year.New prescript
Express News | Evoke Pharma Sees FY24 Net Revenue ~$14M Vs $14.017M Est
Recap: Evoke Pharma Q4 Earnings
Evoke Pharma (NASDAQ:EVOK) reported its Q4 earnings results on Thursday, March 14, 2024 at 04:10 PM.Here's what investors need to know about the announcement.EarningsEvoke Pharma missed estimated earn
Express News | Evoke Pharma Q4 2023 GAAP EPS $(0.59) Misses $(0.50) Estimate, Sales $1.676M Beat $1.632M Estimate
Notable Earnings After Thursday's Close
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersMolina Healthcare (NYSE:MOH) stock moved upwards by 24.2% to $503.11 during Wednesday's after-market session. The company's market cap stands at $29.3 billion. Evoke Pharma (NASDAQ:EVOK) shares
Express News | Laurence W. Lytton Reports In 13G Filing A 9.99% Stake In Evoke Pharma
A Preview Of Evoke Pharma's Earnings
Evoke Pharma (NASDAQ:EVOK) is set to give its latest quarterly earnings report on Thursday, 2024-03-14. Here's what investors need to know before the announcement.Analysts estimate that Evoke Pharma w
Evoke Pharma to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024
SOLANA BEACH, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases with an emphasis on Gimoti
Evoke Pharma Faces Nasdaq Delisting Over Stock Price
Evoke Pharma Bolsters Funding With Equity and Warrants Sale
Evoke Pharma Announces Closing of $7.5 Million Public Offering
SOLANA BEACH, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on
Evoke Pharma Announces Pricing of Recent Offering
Analysis
Price Target
No Data
